Advertisement

Age Related Changes in Adults with Acute Leukemia

  • Charles A. Schiffer
  • O. Ross McIntyre
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 330)

Abstract

There are well known differences between children and adults in both the incidence of different types of acute leukemia and the response to treatment. Whereas acute lymphoblastic leukemia (ALL) constitutes 85–90% of cases of acute leukemia in children, the converse is true in adults, approximately 85% of whom have acute myeloid leukemia. There are no proven explanations for this discrepancy in incidence, although it has been postulated that the antigenic stimulation of new clones of lymphocytes during the maturation of the immune system in infants and children may be associated with an increased mutation rate and hence leukemias occurring in cells of lymphoid lineage (1). There are also major differences in responsiveness to therapy, particularly in ALL where there is a progressive age related decline in both initial complete response rate as well as long term disease free survival; adolescents fare more poorly than younger children with subsequent decreases in survival with advancing patient age in adults (Figure l)(2–8).

Keywords

Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Acute Leukemia Philadelphia Chromosome Childhood Acute Lymphoblastic Leukemia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Greaves, M.F. Speculations on the causes of childhood acute lymphoblastic leukemia. Leukemia 2:120 (1988).PubMedGoogle Scholar
  2. 2.
    Gaynor, J., Chapman, D., Little, C., McKenzie, S., Miller, W., Andreeff, M., Arlin, Z., Berman, E., Kempin, S., Gee, T., Clarkson, B. A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the memorial hospital experience since 1969. J. Clin. Oncol. 6:1014 (1988).PubMedGoogle Scholar
  3. 3.
    Baccarani, M., Carbelli, G., Amadori, S., Drenthe-Schonk, A., Willemze, R., Meloni, G., Cardozo, P.L., Haanen, C., Mandelli, F., Tura, S. Adolescent and adult acute lymphoblastic leukemia: prognostic features and outcome of therapy. A study of 293 patients. Blood 60:677 (1982).PubMedGoogle Scholar
  4. 4.
    Crist, W., Pullen, J., Boyett, J., Falletta, J., van Eys, J., Borowitz, M., Jackson, J., Dowell, B., Russell, C., Quddus, F., Ragab, A., Vietti, T. Acute lymphoid leukemia in adolescents: clinical and biologic features predict a poor prognosis-a Pediatric Oncology Group study. J. of Clin. Onc. 6:34 (1987).Google Scholar
  5. 5.
    Linker, C.A., Levitt, L.J., O’Donnell, M., Reis, C.A., Link, M.P., Forman, S.J., Farbstein, M.J. Improved results of treatment of adult acute lymphoblastic leukemia. Blood 69:1242 (1987).PubMedGoogle Scholar
  6. 6.
    Gottlieb, A.J., Weinberg, V., Ellison, R.R., Henderson, E.S., Terebelo, H., Rafla, S., Cuttner, J., Silver, R.T., Carey, R.W., Levy, R.N., Hutchinson, J.L., Raich, P., Cooper, M.R., Wiernik, P., Anderson, J.R., Holland, J.F. Efficacy of daunorubicin in the therapy of adult acute lymphocytic leukemia: a prospective randomized trial by Cancer and Leukemia Group B. Blood 64:267 (1984).PubMedGoogle Scholar
  7. 7.
    Ellison, P.R., Mick, R., Cuttner, J., Schiffer, C., Sobol, R. Prognostic factors affecting response and survival in adults with acute lymphocytic leukemia treated on CALGB 8011. Proc. Am. Soc. Clin. Oncol. 5:156 (1986).Google Scholar
  8. 8.
    Hoelzer, D., Thiel, E., Loffler, H., Buchner, T., Ganser, A., Heil, G., Koch, P., Freund, M., Diedrich, H., Ruhl, H., Maschmeyer, G., Lipp, T., Nowrousian, M.R., Burkert, M., Gerecke, D., Pralle, H., Muller, U., Lunscken, C.H., Fulle, H., Ho, A.D., Kuchler, R., Busch, F.W., Schneider, W., Gorg, C.H., Emmerich, B., Braumann, D., Vaupel, H.A., von Paleske, A., Bartels, H., Neiss, A., Messerer, D. Progostic factors in multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 71:123 (1988).PubMedGoogle Scholar
  9. 9.
    Schiffer, C.A., Wade, J.A. Supportive Care: Issues in the use of blood products and treatment of infection. Semin. Oncol. 14:454 (1987).PubMedGoogle Scholar
  10. 10.
    Mayer, R.J., Schiffer, C.A., Peterson, B.A., Silver, R.T., Cornwell, G.G., Rai, K.R., Ellison, R.R., Maguire, M., Berg, D., Davis, R.B., Mclntyre, O.R., Frei, E. Intensive post-remission therapy in adults with acute nonlymphocytic leukemia using various dose schedules of Ara-C: A progress report from the CALGB. Semin. Oncol. 14:25–31 (1987).PubMedGoogle Scholar
  11. 11.
    Preisler, H., Davis, R.B., Kirshner, J., Dupre, E., Richards, III F., Hoagland, H.C., Kopel, S., Levy, R.N., Carey, R., Schulman, P., Gottleib, A.J., Mclntyre, O.R., and the Cancer and Leukemia Group B. Comparison of three remission induction regimens and two postinduction strategies for the treatment of acute nonlymphocytic leukemia: A Cancer and Leukemia Group B study. Blood 69:1441 (1987).PubMedGoogle Scholar
  12. 12.
    Rai, K.R., Holland, J.F., Glidewell, O.J., Weinberg, V., Brunner, K., Obrecht, J.P., Preisler, H.D., Nawabi, I.W., Prager, D., Carey, R.W., Cooper, M.R., Haurani, F., Hutchinson, J.L., Silver, R.T., Falkson, G., Wiernik, P., Hoagland, H.C., Bloomfield, C.D., James, G.W., Gottlieb, A., Ramanan, S.V., Blom, J., Nissen, N.I., Bank, A., Ellison, R.R., Kung, F., Henry, P., Mclntyre, O.R., Kaan, S.K. Treatment of acute myelocytic leukemia: a study by Cancer and Leukemia Group B. Blood 58:1203 (1981).PubMedGoogle Scholar
  13. 13.
    Schiffer, C.A., Mayer, R.J. for CALGB, Cancer and Leukemia Group B (CALGB) Studies in Acute Myeloid Leukemia. In: Acute Myelogenous Leukemia. R.P. Gale (eds), Wiley/Liss (in press).Google Scholar
  14. 14.
    Berger, R., Bemheim, A., Ochoa-Noguera, M.E., Daniel, M.T., Valensi, F., Sigaux, F., Flandrin, G., Boiron, M. Prognostic significance of chromosomal abnormalities in acute nonlymphocytic leukemia: a study of 343 patients. Can. Genet. Cytogenet. 28:293 (1987).CrossRefGoogle Scholar
  15. 15.
    Fourth International Workshop on Chromosomes in Leukemia, 1982. Clinical significance of chromosomal abnormalities in acute non-lymphoblastic leukemia. Can. Genet. Cytogenet. 11:332 (1984).Google Scholar
  16. 16.
    Keating, M.J., Cork, A., Broach, Y., Smith, T., Walters, R.S., McCredie, K.B., Trujillo, J., Freireich, E.J. Toward a clinically relevant cytogenetic classification of acute myelogenous leukemia. Leukemia Res. 11:119 (1987).CrossRefGoogle Scholar
  17. 17.
    Samuels, B.L., Larson, R.A., Le Beau, M.M., Daly, K.M., Bitter, M.A., Vardiman, J.W., Barker, C.M., Rowley, J.D., Golomb, H.M. Specific chromosomal abnormalties in acute nonlymphocytic leukemia correlate with drug susceptibility in vivo. Leukemia 2:79 (1988).PubMedGoogle Scholar
  18. 18.
    Schiffer, C.A., Lee, E.J., Tomiyasu, T., Wiernik, P.H., Testa, J.R. Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemia Blood 73:263 (1989).PubMedGoogle Scholar
  19. 19.
    Rowley, J.D. Association of specific chromosome abnormalities with type of acute leukemia and with patient age. Can. Res. 41:3407 (1981).Google Scholar
  20. 20.
    Golomb, H.M., Alimena, G., Rowley, J.D. Correlation of occupation and karyotype in adults with acute nonlymphocytic leukemia. Blood 60:404 (1982).PubMedGoogle Scholar
  21. 21.
    Keinänen, M., Griffin, J.D., Bloomfield, C.D., Machnicki, J., de la Chapelle, A. Clonal chromosomal abnormalities showing multiple-cell-lineage involvement in acute myeloid leukemia. New England J Medicine 318:1153 (1988).CrossRefGoogle Scholar
  22. 22.
    Lee, E.J., Pollak, A., Leavitt, R.D., Testa, J.R., Schiffer, C.A. Minimally differentiated acute nonlymphocytic leukemia: A distinct entity. Blood 70:1400 (1987).PubMedGoogle Scholar
  23. 23.
    Vaughan, W.P., Civin, C.I., Weisenburger, D.D., Karp, J.E., Graham, M.L., Sanger, W.G., Grierson, H.L., Joshi, S.S., Burke, P.J. Acute leukemia expressing the normal human hematopoietic stem cell membrane glycoprotein CD34 (MY10). Leukemia 2:661 (1988).PubMedGoogle Scholar
  24. 24.
    Borowitz, M.J., Gockerman, J.P., Moore, J.O., Civin, C.I., Page, S.O., Robertson, J., Bigner, S.H. Clinicopathologic and cytogenetic features of CD34 (My 10)-positive acute nonlymphocytic leukemia. Am. J. Clin. Pathol. 91:265 (1989).PubMedGoogle Scholar
  25. 25.
    Moscow, J.A., Cowan, K.H. Review: Multidrug resistance. J. Natl. Cancer Inst. 80:14 (1988).PubMedCrossRefGoogle Scholar
  26. 26.
    Sobol, R.E., Royston, I., LeBien, T.W., Minowada, J., Anderson, K., Davey, F.R., Cuttner, J., Schiffer, C., Ellison, R.R., Bloomfield, C.D, Adult acute lymphoblastic leukemia phenotypes defined by monoclonal antibodies. Blood 64:730 (1985).Google Scholar
  27. 27.
    Hoelzer, D., Thiel, E., Loffler, H., Buchner, T., Freund, M., Ganser, A., Heil, G., Hiddemann, W., Maschmeyer, G., Aul, C., Wendt, F.C., Bross, K., Pralle, H., Kuchler, R., Dietrich, H., Mettnernich, M., Lindemann, A., Lipp, T., Kaboth, W., Nowrousian, M.R., Koch, P., Busch, F.W., Heimpel, H., Gotz, G., Weiss, A., Kolb, H., Messerer, D. Intensification chemotherapy and mediastinal irradiation in adult T-cell acute lymphoblastic leukemia. In: R.P. Gale & D. Hoelzer, eds. “Acute Lymphoblastic Leukemia”, New York, p. 221-229 (1990).Google Scholar
  28. 28.
    Sobol, R.E., Rosemarie, M., Royston, I., Davey, F.R., Ellison, R.R., Newman, R., Cuttner, J., Griffin, J.D., Collins, H., Nelson, D.A., Bloomfield, C.D. Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. New Eng. J. Med. 316:1111(1987).PubMedCrossRefGoogle Scholar
  29. 29.
    Mirro, J., Zipf, T.F., Pui, C-H., Kitchingman, G., Williams, D., Melvin, S., Murphy, S.B., Stass, S. Acute Mixed Lineage Leukemia: clinicopathologic correlations and prognostic significance. Blood 66:1115 (1985).PubMedGoogle Scholar
  30. 30.
    Schiffer, C.A. Hybrid Leukemias. In: R.P. Gale & D. Hoelzer, eds. “Acute Lymphoblastic Leukemia”, New York, p. 129-142 (1990).Google Scholar
  31. 31.
    Ball, E.D., Griffin, J.D., Davis, R., Davey, F.R., Arthur, D., Wurster-Hill, D., Schiffer, C., Bloomfield, C.D. Prognostic value of lymphocyte surface markers in acute myeloid leukemia (AML): A Cancer and Leukemia Group B (CALGB) Study. Blood 72:187 (1988).Google Scholar
  32. 32.
    Williams, D.L., Raimondi, S.C., Pui, C-H., Rivera, G.K. Evolving chromosome patterns and new cytogenetic concepts in childhood acute lymphoblastic leukemia. In: R.P. Gale & D. Hoelzer, eds. “Acute Lymphoblastic Leukemia”, New York, p. 91-100 (1990).Google Scholar
  33. 33.
    Williams, D.L., Harber, J., Murphy, S.B., Look, T.A., Kalwinksy, D.K., Rivera, G., Melvin, S.L., Stass, S., Dahl, G.V. Chromosomal translocations play a unique role in influencing prognosis in childhood acute lymphoblastic leukemia. Blood 68:205 (1986).PubMedGoogle Scholar
  34. 34.
    Crist, W., Carroll, A., Shuster, J., Jackson, J., Head, D., Borowitz, M., Behm, F., Link, M., Steuber, P., Ragab, A., Hirt, A., Brock, B., Land, V., Pullen, J. Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A pediatric oncology group study. Blood 76:489 (1990).PubMedGoogle Scholar
  35. 35.
    Bloomfield, C.D., Goldman, A.I., Alimena, G., Berger, R., Borgstrom, G.H., Brandt, L., Catovsky, D., de la Chapelle, A., Dewald, G.W., Garson, O.M., Garwicz, S., Golomb, H.M., Hossfeld, D.K., Lawler, S.D., Mitelman, F., Nilsson, P., Pierre, R.V., Philip, P., Prigogina, E., Rowley, J.D., Sakurai, M., Sandberg, A.A., Secker Walker, L.M., Tricot, G., Van Den Berghe, H., Van Orshoven, A., Vuopio, P., Whang-Peng, J. Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia. Blood 67:415 (1986).PubMedGoogle Scholar
  36. 36.
    Kurzrock, R., Gutterman, J.U., Talpaz, M. The molecular genetics of Philadelphia chromosome-positive leukemias. New Eng. J. Med., 319:990 (1988).PubMedCrossRefGoogle Scholar
  37. 37.
    Hooberman, A.L., Rubin, C.M., Barton, K.P., Westbrook, C.A. Detection of the Philadelphia chromosome in acute lymphoblastic leukemia by pulsed-field gel electorphoresis. Blood 74:1101 (1989).PubMedGoogle Scholar
  38. 38.
    Hooberman, A.L., Westbrook, C.A., Davey, F., Schiffer, G., Spino, G., Bloomfield, C.D. Molecular detection of the Philadelphia chromosome (PH1) chromosome in adult acute lymphoblastic leukemia (ALL): clinical cytogenetic, and immunophenotypic correlations in a CALGB study. Blood 74:183 (1989).Google Scholar
  39. 39.
    Bloomfield, C.D., Wurster-Hill, D., Peng, G., Le Beau, M., Tantravahi, R., Testa, J., Davey, F.R., Ellison, R.R., Cuttner, J., Schiffer, C., Sobol, R.E., Lunghofer, B., Carey, M., Mick, R., Arthur, D. Prognostic significance of the Philadelphia chromosome in adult acute lymphoblastic leukemia. In: R.P. Gale & D. Hoelzer, eds. “Acute Lymphoblastic Leukemia”, New York, p. 101-109 (1990).Google Scholar
  40. 40.
    Forman, S.J., O’Donnell, M.R., Nademanee, A.P. Bone marrow transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 70:587 (1987).PubMedGoogle Scholar
  41. 41.
    Evans, W.E., Crom, W.R., Abromowitch, M., Dodge, R., Look, A.T., Bowman, W.P., George, S.L., Pui, C.H. Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. New Eng. J. Med. 314:471 (1986).PubMedCrossRefGoogle Scholar
  42. 42.
    Lennard, L., Lilleyman, J.S. Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia. J. Clin. Oncol. 7:1816 (1989).PubMedGoogle Scholar
  43. 43.
    Capizzi, R.L., Oliver, L., Friedman, J., Davis, R., Mayer R., Schiffer, C.A. Variations in Ara-C plasma concentrations at steady-state (C-ss) during remission induction and intensification therapy of AML. A population pharmacokinetics study by CALGB. Proc. Amer. Soc. Clin. Onc. 7:57 (1988).Google Scholar
  44. 44.
    Clavell, L.A., Gelber, R.D., Cohen, HJ., Hitchcock-Bryan, S., Cassady, J.R., Tarbeil, N.J., Blattner, S.R., Tantravahi, R., Leavitt, P., Sallan, S.E. Fouragent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia. New Eng. J. Med. 315:657 (1986).PubMedCrossRefGoogle Scholar
  45. 45.
    Steinherz, P.G., Gaynon, P., Miller, D.R., Reaman, G., Bleyer, A., Finklestein, J., Evans, R.G., Meyers, P., Steinherz, L.J., Sather, H., Hammond, D. Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen — a new intensive therapy protocol: a report from the Children’s Cancer Study Group. J. of Clin. Onc. 4:744 (1986).Google Scholar
  46. 46.
    LeBien, T.W., McCormack, T. The common acute lymphoblastic leukemia antigen (CD10): emancipation from a functional enigma. Blood 73:625 (1989).PubMedGoogle Scholar
  47. 47.
    Barrett, J.A., Horowitz, M.M., Gale, R.P., Biggs, J.C., Camitta, B.M., Dicke, K.A., Gluckman, E., Good, R.A., Herzig, H., Lee, M.B., Marmont, A.M., Masaoka, T., Ramsay, N.K.C., Rimm, A.A., Speck, B., Zwaan, F.E., Bortin, M.M. Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival. Blood 74:862 (1989).PubMedGoogle Scholar
  48. 48.
    Groopman, J.E., Molina, J.M., Scadden, D.T. Hematopoietic growth factors: biology and clinical applications. New Eng. J. Med. 321:1449 (1989).PubMedCrossRefGoogle Scholar
  49. 49.
    Büchner, T., Hiddemann, W., Koenigsmann, M., Zuhlsdorf, M., Wormann, B., Boeckmann, A., van de Loo, J., Maschmeyer, G., Wendt, F., Schulz, G. Human recombinant granulocyte macrophage colony stimulating factor (GM-CSF) for acute leukemias in aplasia and at high risk of early death. Blood 72:111a (1989).Google Scholar
  50. 50.
    Muhm, M., Andreeff, M., Geissler, K., Gorischek, C., Haas, O., Haimi, J., Hinterberger, W., Schulz, G., Speiser, W., Sunder-Plassmann, G., Valent, P., Lechner, K., Bettelheim, P. RhGM-CSF in combination with chemotherapy — a new strategy in the therapy of acute myeloid leukemia. Blood 74:117a (1989).Google Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • Charles A. Schiffer
    • 1
  • O. Ross McIntyre
    • 2
    • 3
  1. 1.Division of Hematologic MalignanciesUniversity of Maryland Cancer Center, School of MedicineBaltimoreUSA
  2. 2.Norris Cotton Cancer CenterDartmouth Medical SchoolHanoverUSA
  3. 3.Cancer and Leukemia GroupLebanonUSA

Personalised recommendations